Vatche Agopian

Title: Vatche Agopian: Innovator in Hepatocellular Carcinoma Detection

Introduction

Vatche Agopian is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment selection for hepatocellular carcinoma.

Latest Patents

Agopian holds a patent titled "Phenotypic profiling of hepatocellular carcinoma circulating tumor cells for treatment selection." This patent encompasses methods and kits for detecting hepatocellular carcinoma recurrence or metastasis. The innovative approach involves measuring markers of hepatocellular carcinoma in a blood sample obtained from a subject. The process includes isolating circulating tumor cells (CTCs) using capture antibodies that specifically bind to asialoglycoprotein receptor (ASGPR), Glypican-3, and epithelial cell adhesion molecule (EpCAM). Following this, the isolated CTCs are contacted with an antibody that specifically binds vimentin, allowing for the measurement of vimentin-positive CTCs.

Career Highlights

Agopian is affiliated with the University of California, where he continues to advance research in cancer diagnostics. His work has the potential to significantly impact treatment strategies for patients diagnosed with hepatocellular carcinoma.

Collaborations

He has collaborated with esteemed colleagues such as Hsian-Rong Tseng and Shuang Hou, contributing to the advancement of research in his field.

Conclusion

Vatche Agopian's innovative work in the detection of hepatocellular carcinoma showcases his commitment to improving cancer diagnostics and treatment selection. His contributions are vital in the ongoing battle against cancer, and his patent reflects a significant advancement in medical technology.